X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs DIVIS LABORATORIES - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD DIVIS LABORATORIES ALEMBIC LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 76.8 18.5 416.1% View Chart
P/BV x 2.9 4.0 71.4% View Chart
Dividend Yield % 0.4 1.5 25.4%  

Financials

 ALEMBIC LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
DIVIS LABORATORIES
Mar-16
ALEMBIC LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs532,484 2.1%   
Low Rs29918 3.2%   
Sales per share (Unadj.) Rs4.7142.3 3.3%  
Earnings per share (Unadj.) Rs8.841.9 20.9%  
Cash flow per share (Unadj.) Rs9.046.3 19.4%  
Dividends per share (Unadj.) Rs0.1510.00 1.5%  
Dividend yield (eoy) %0.40.6 62.2%  
Book value per share (Unadj.) Rs27.7161.5 17.2%  
Shares outstanding (eoy) m267.03265.47 100.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.712.0 72.7%   
Avg P/E ratio x4.740.6 11.5%  
P/CF ratio (eoy) x4.636.7 12.4%  
Price / Book Value ratio x1.510.5 14.1%  
Dividend payout %1.723.9 7.2%   
Avg Mkt Cap Rs m10,962451,525 2.4%   
No. of employees `000NA3.7 0.0%   
Total wages/salary Rs m2383,649 6.5%   
Avg. sales/employee Rs ThNM10,184.4-  
Avg. wages/employee Rs ThNM984.1-  
Avg. net profit/employee Rs ThNM2,998.5-  
INCOME DATA
Net Sales Rs m1,26037,764 3.3%  
Other income Rs m264848 31.1%   
Total revenues Rs m1,52438,612 3.9%   
Gross profit Rs m8314,138 0.6%  
Depreciation Rs m611,182 5.2%   
Interest Rs m023 1.3%   
Profit before tax Rs m28513,781 2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m62,662 0.2%   
Profit after tax Rs m2,34311,119 21.1%  
Gross profit margin %6.637.4 17.5%  
Effective tax rate %2.119.3 11.1%   
Net profit margin %185.929.4 631.4%  
BALANCE SHEET DATA
Current assets Rs m1,68930,947 5.5%   
Current liabilities Rs m4865,195 9.4%   
Net working cap to sales %95.468.2 139.9%  
Current ratio x3.56.0 58.3%  
Inventory Days Days217117 185.8%  
Debtors Days Days8185 95.2%  
Net fixed assets Rs m1,62417,027 9.5%   
Share capital Rs m534531 100.6%   
"Free" reserves Rs m5,96042,341 14.1%   
Net worth Rs m7,40442,877 17.3%   
Long term debt Rs m1045 2,219.1%   
Total assets Rs m8,01049,684 16.1%  
Interest coverage x950.7595.0 159.8%   
Debt to equity ratio x00 12,851.4%  
Sales to assets ratio x0.20.8 20.7%   
Return on assets %29.322.4 130.4%  
Return on equity %31.625.9 122.0%  
Return on capital %31.332.2 97.2%  
Exports to sales %2.985.3 3.5%   
Imports to sales %28.922.9 125.9%   
Exports (fob) Rs m3732,198 0.1%   
Imports (cif) Rs m3648,654 4.2%   
Fx inflow Rs m3732,270 0.1%   
Fx outflow Rs m3658,775 4.2%   
Net fx Rs m-32823,496 -1.4%   
CASH FLOW
From Operations Rs m34610,379 3.3%  
From Investments Rs m-48-4,135 1.2%  
From Financial Activity Rs m-301-6,241 4.8%  
Net Cashflow Rs m-33 -90.9%  

Share Holding

Indian Promoters % 64.0 52.0 123.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 11.8 1.7%  
FIIs % 9.7 19.0 51.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.2 151.7%  
Shareholders   54,701 31,796 172.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  MERCK LTD  NOVARTIS  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - DIVIS LABORATORIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS